tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joseph Munda, 17 are a BUY (77.27%), 5 are a HOLD (22.73%).
Analyst Joseph Munda, currently employed at FIRST ANALYSIS, carries an average stock price target met ratio of 97.62% that have a potential upside of 18.08% achieved within 461 days.
Joseph Munda’s has documented 47 price targets and ratings displayed on 8 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on NEO, NeoGenomics at 27-Feb-2020.
Analyst best performing recommendations are on ANIK (ANIKA THERAPEUTICS).
The best stock recommendation documented was for NEO (NEOGENOMICS) at 10/24/2018. The price target of $18 was fulfilled within 7 days with a profit of $3.7 (25.87%) receiving and performance score of 36.96.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 31-Jul-2025
$21
$1.9 (9.95%)
$16
2 months 7 days ago
(30-Jul-2026)
2/2 (100%)
$2.93 (16.21%)
134
Buy Since 03-Nov-2023
$17
$1.9 (12.58%)
$16
7 months 10 days ago
(27-Feb-2026)
14/22 (63.64%)
$2.64 (18.38%)
129
Hold Since 14-Oct-2022
$24
$8.9 (58.94%)
$23
2 years 4 months 8 days ago
(29-May-2024)
5/5 (100%)
$-1.64 (-6.40%)
129
Buy Since 09-Aug-2023
$32
$12.9 (67.54%)
3 years 1 months 28 days ago
(09-Aug-2023)
1/2 (50%)
$11.99 (59.92%)
73
Buy Since 15-Nov-2021
$35
$15.9 (83.25%)
$55
4 years 6 months 28 days ago
(09-Mar-2022)
0/2 (0%)
$8.78 (33.49%)
What Year was the first public recommendation made by Joseph Munda?
